A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility
- 1 January 2007
- journal article
- clinical trial
- Published by Taylor & Francis Ltd in Gynecological Endocrinology
- Vol. 23 (2), 76-81
- https://doi.org/10.1080/09513590601137509
Abstract
Background. In the present study we evaluated and compared the effects of ovulation and hormonal dynamics induced by anastrozole and clomiphene citrate in women with infertility. Materials and methods. Thirty-three infertile patients, aged 25–41 years, were enrolled. Patients received either anastrozole 1 mg daily (AI group) or clomiphene citrate 100 mg daily (CC group) from cycle day 3 to day 7. Number of mature follicles (≥18 mm), endometrial thickness, pregnancy rate and serial hormone profiles (follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), testosterone and progesterone) were measured on cycle day 3, day 8, day 10, the day of intrauterine insemination (IUI), day 7 after IUI and day 14 after IUI. Results. Baseline parameters were similar in the two groups, including age, body mass index, infertility duration and day-3 serum hormones except FSH. The mean FSH value on day 3 was significantly different (4.3 mIU/ml in the AI group vs. 6.3 mIU/ml in the CC group; p < 0.05). The women receiving anastrozole had fewer ovulatory follicles (1.2 in the AI group vs. 1.8 in the CC group; p < 0.05) and a thicker endometrium (10.6 mm in the AI group vs. 7.8 mm in the CC group; p < 0.05). The levels of progesterone and testosterone were similar during ovulation stimulation cycles in both groups. On the other hand, the AI group had a significantly higher LH level but a significantly lower E2 level in the stimulation cycle. Conclusion. Anastrozole has a high pregnancy rate, although it induces fewer ovulatory follicles compared with clomiphene citrate. The two drugs gave different responses of FSH, LH and E2 during stimulation cycles.Keywords
This publication has 16 references indexed in Scilit:
- The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot studyFertility and Sterility, 2005
- The aromatase inhibitor anastrozole is associated with favorable embryo development and implantation markers in mice ovarian stimulation cyclesFertility and Sterility, 2005
- ATAC trial updateThe Lancet, 2005
- Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulationAmerican Journal of Obstetrics and Gynecology, 2005
- Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patientsFertility and Sterility, 2005
- A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteersFertility and Sterility, 2004
- A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulationFertility and Sterility, 2004
- Aromatase inhibitors: possible future applicationsActa Obstetricia et Gynecologica Scandinavica, 2004
- Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitorThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Regulation by Follicle-Stimulating Hormone of the Synthesis of Aromatase Cytochrome P-450 in Human Granulosa CellsMolecular Endocrinology, 1987